InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Janda Kim, Director. Insider active across 1 company, notably Sorrento Therapeutics, Inc.. Aggregated, 3 filings have been published. History available since 13 September 2021. The latest transaction was disclosed on 27 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Janda Kim is a Board Member at Sorrento Therapeutics, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Kim brings her expertise to guide the direction of Sorrento and ensure compliance with governance standards. Her commitment to operational excellence is a valuable asset to the board.